About this trial
To understand the impact of thumb-tack needle therapy on postoperative sleep and recovery in patients who have undergone general anesthesia, and to explore the clinical significance of thumb-tack needle therapy in improving postoperative sleep quality, preventing postoperative sleep disorders, and promoting postoperative recovery
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing breast cancer surgery with general anesthesia in the hospital;
American Society of Anesthesiologists (ASA) classification I-II;
Women aged 18-55 years;
No history of chronic insomnia;
Disqualifiers
Those who do not meet the aforementioned inclusion criteria;
A history of severe heart, brain, lung, or kidney diseases (such as acute coronary syndrome (ACS), severe heart failure classified as NYHA Class III or IV, severe arrhythmias, severe valvular disease; acute aortic disease, and severe peripheral vascular disease, etc.), or poor physical condition (including reduced exercise tolerance, multi-organ dysfunction, malnutrition, etc.);
A history of sleep disorders and psychiatric history;
Inability to receive thumb-tack needle treatment.
Trial population
Patients undergoing breast cancer surgery with general anesthesia in the hospital
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Pittsburgh sleep quality index(PSQI)
Total scores range from 0 to 21, with higher scores indicating worse sleep quality.
Secondary outcomes
Later Recovery evaluated by QoR-40 questionnaire
The maximum total score is 200, with higher scores indicating better recovery quality
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
The First Affiliated Hospital of Xiamen University
Lead sponsor
Fujian Medical University
Sponsor institution